Cargando…
Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinoma
BACKGROUND: Clear cell renal cell carcinoma (ccRCC) is a malignant tumor with heterogeneous morphology and poor prognosis. This study aimed to establish a DNA methylation (DNAm)-driven gene-based prognostic model for ccRCC. METHODS: Reduced representation bisulfite sequencing (RRBS) was performed on...
Autores principales: | Deng, Qiong, Du, Ye, Wang, Zhu, Chen, Yeda, Wang, Jieyan, Liang, Hui, Zhang, Du |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249168/ https://www.ncbi.nlm.nih.gov/pubmed/37286941 http://dx.doi.org/10.1186/s12864-023-09416-z |
Ejemplares similares
-
Prognostic Value of DNA Methylation-Driven Genes in Clear Cell Renal Cell Carcinoma: A Study Based on Methylation and Transcriptome Analyses
por: Hu, Maolin, et al.
Publicado: (2020) -
Identification of methylation‐driven genes related to prognosis in clear‐cell renal cell carcinoma
por: Wang, Jia, et al.
Publicado: (2019) -
Four methylation‐driven genes may be prognostic biomarkers in clear cell renal carcinoma
por: Yin, Hang, et al.
Publicado: (2020) -
Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients
por: Li, Zhengtian, et al.
Publicado: (2021) -
Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma
por: Chen, Guang, et al.
Publicado: (2016)